As of today, common shares of Santé Veritas Holdings Inc., parent company of late-stage ACMPR applicant Santé Veritas Therapeutics, have been approved for listing on the CSE.
Sante is focused on developing its business in the emerging cannabis market, with a specific focus on the wholesale sector of the medical cannabis market in Canada. It's wholly-owned L.P. applicant subsidiary expects to obtain Licensed Producer status later in 2018.
Health Canada recently issued Santé Veritas Therapeutics a “confirmation of readiness” for a license under the Access to Cannabis for Medical Purposes Regulations confirming its initial annual cultivation request of 2,835,000 grams of cannabis flower, making it one of the larger Licensed Producers out there.
Shares will trade under the symbol SV on the CSE, beginning tomorrow May 10th, 2018.